FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898616210> ?p ?o ?g. }

• W2898616210 endingPage "412" @default.
• W2898616210 startingPage "412" @default.
• W2898616210 abstract "Systemic therapy for hepatocellular carcinoma (HCC) has changed drastically since the introduction of the molecular targeted agent sorafenib in 2007. Although sorafenib expanded the treatment options for extrahepatic spread (EHS) and vascular invasion, making long-term survival of patients with advanced disease achievable to a certain extent, new molecular-targeted agents are being developed as alternatives to sorafenib due to shortcomings such as its low response rate and high toxicity. Every single one of the many drugs developed during the 10-year period from 2007 to 2016 was a failure. However, during the two-year period from 2017 through 2018, four drugs—regorafenib, lenvatinib, cabozantinib, and ramucirumab—emerged successfully from clinical trials in quick succession and became available for clinical use. The efficacy of combination therapy with transcatheter arterial chemoembolization (TACE) plus sorafenib was also first demonstrated in 2018. Recently, immune checkpoint inhibitors have been applied to HCC treatment and many phase III clinical trials are ongoing, not only on monotherapy with nivolumab, pembrolizumab, and tislelizumab, but also on combination therapy with checkpoint inhibitors, programmed death-1 (PD-1) or PD-ligand 1 (PD-L1) antibody plus a molecular targeted agent (bevacizumab) or the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) antibody, tremelimumab. These combination therapies have shown higher response rates than PD-1/PD-L1 monotherapy alone, suggesting a synergistic effect by combination therapy in early phases; therefore, further results are eagerly awaited." @default.
• W2898616210 created "2018-11-09" @default.
• W2898616210 creator A5032900701 @default.
• W2898616210 date "2018-10-30" @default.
• W2898616210 modified "2023-10-01" @default.
• W2898616210 title "Systemic Therapy for Hepatocellular Carcinoma: Latest Advances" @default.
• W2898616210 cites W1538902372 @default.
• W2898616210 cites W1633413258 @default.
• W2898616210 cites W1828082159 @default.
• W2898616210 cites W1968209756 @default.
• W2898616210 cites W1971837077 @default.
• W2898616210 cites W1973526660 @default.
• W2898616210 cites W1990095055 @default.
• W2898616210 cites W1994193851 @default.
• W2898616210 cites W1996229105 @default.
• W2898616210 cites W2022144305 @default.
• W2898616210 cites W2046000826 @default.
• W2898616210 cites W2051684210 @default.
• W2898616210 cites W2063264144 @default.
• W2898616210 cites W2094109552 @default.
• W2898616210 cites W2094366129 @default.
• W2898616210 cites W2115991409 @default.
• W2898616210 cites W2119242310 @default.
• W2898616210 cites W2120967735 @default.
• W2898616210 cites W2122639773 @default.
• W2898616210 cites W2128965737 @default.
• W2898616210 cites W2140765540 @default.
• W2898616210 cites W2151600653 @default.
• W2898616210 cites W2158207366 @default.
• W2898616210 cites W2162856391 @default.
• W2898616210 cites W2286222994 @default.
• W2898616210 cites W2528882804 @default.
• W2898616210 cites W2557650597 @default.
• W2898616210 cites W2558253459 @default.
• W2898616210 cites W2560499218 @default.
• W2898616210 cites W2566983339 @default.
• W2898616210 cites W2569886419 @default.
• W2898616210 cites W2580579569 @default.
• W2898616210 cites W2587257382 @default.
• W2898616210 cites W2604339938 @default.
• W2898616210 cites W2606367731 @default.
• W2898616210 cites W2661307008 @default.
• W2898616210 cites W2745488932 @default.
• W2898616210 cites W2759382352 @default.
• W2898616210 cites W2762066258 @default.
• W2898616210 cites W2762518662 @default.
• W2898616210 cites W2765356289 @default.
• W2898616210 cites W2765455407 @default.
• W2898616210 cites W2774520615 @default.
• W2898616210 cites W2780555458 @default.
• W2898616210 cites W2787358630 @default.
• W2898616210 cites W2789297669 @default.
• W2898616210 cites W2791060618 @default.
• W2898616210 cites W2791703762 @default.
• W2898616210 cites W2795488377 @default.
• W2898616210 cites W2795708663 @default.
• W2898616210 cites W2799933121 @default.
• W2898616210 cites W2802019690 @default.
• W2898616210 cites W2805592007 @default.
• W2898616210 cites W2808082897 @default.
• W2898616210 cites W2809889937 @default.
• W2898616210 cites W2888117448 @default.
• W2898616210 cites W2888313539 @default.
• W2898616210 cites W2889699338 @default.
• W2898616210 cites W2890595557 @default.
• W2898616210 cites W2892063440 @default.
• W2898616210 cites W2892167977 @default.
• W2898616210 doi "https://doi.org/10.3390/cancers10110412" @default.
• W2898616210 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6266463" @default.
• W2898616210 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30380773" @default.
• W2898616210 hasPublicationYear "2018" @default.
• W2898616210 type Work @default.
• W2898616210 sameAs 2898616210 @default.
• W2898616210 citedByCount "132" @default.
• W2898616210 countsByYear W28986162102019 @default.
• W2898616210 countsByYear W28986162102020 @default.
• W2898616210 countsByYear W28986162102021 @default.
• W2898616210 countsByYear W28986162102022 @default.
• W2898616210 countsByYear W28986162102023 @default.
• W2898616210 crossrefType "journal-article" @default.
• W2898616210 hasAuthorship W2898616210A5032900701 @default.
• W2898616210 hasBestOaLocation W28986162101 @default.
• W2898616210 hasConcept C121608353 @default.
• W2898616210 hasConcept C126322002 @default.
• W2898616210 hasConcept C143998085 @default.
• W2898616210 hasConcept C2776248978 @default.
• W2898616210 hasConcept C2776264508 @default.
• W2898616210 hasConcept C2776694085 @default.
• W2898616210 hasConcept C2776999253 @default.
• W2898616210 hasConcept C2777472916 @default.
• W2898616210 hasConcept C2777701055 @default.
• W2898616210 hasConcept C2777802072 @default.
• W2898616210 hasConcept C2778019345 @default.
• W2898616210 hasConcept C2778695046 @default.
• W2898616210 hasConcept C2779551604 @default.
• W2898616210 hasConcept C2780030458 @default.
• W2898616210 hasConcept C2780057760 @default.
• W2898616210 hasConcept C2781064419 @default.

• next